Cormedix inc. (CRMD)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss

-16,433

-26,829

-33,009

-24,643

-18,187

-20,453

-9,133

-3,380

-6,671

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

2,439

1,110

1,659

1,335

3,225

2,168

1,345

274

692

Value of warrants issued in connection with backstop financing

-

-

-

-

-1,583

0

-

-

-

Modification of warrant agreement

-

-

-

-

-112

0

-

-

-

Loss on foreign currency transactions

-

-

-

-

0

150

-

-

-

Stock issued in connection with license agreements

-

-

-

-

-

-

-

0

0

Stock issued in connection with consulting agreement

-

-

-

-

-

-

-

0

0

Warrants issued in connection with license agreement

-

-

-

-

-

-

76

0

-

Amortization of deferred financing costs

-

-

-

-

-

-

282

76

0

Amortization of debt discount

313

-

0

-

-

-

1,054

279

0

Non-cash interest expense

461

-

-

-

-

-

-

-

-

Loss on foreign exchange transactions

-

-

-

-

-

-

0

-

-

Loss on issuance of preferred stock, convertible notes and warrants

-

-

-

-

0

89

945

0

-

Loss on modification of equity instruments and extinguishment of derivative liabilities

-

-

-

-

0

2,462

1,459

-

-

Non-cash charge for beneficial conversion feature

-

-

-

-

-

-

-

0

0

Non-cash interest expense

-

-

-

-

-

-

41

0

0

Inventory reserve

27

-

-327

130

125

175

0

-

-

Loss on modification of equity instruments and extinguishment of derivative liabilities

-

-

-

-

-

-

-

0

-

Change in fair value of derivative liabilities

-

-

-177

0

0

-8,848

-363

0

-

Expenses paid on behalf of the Company satisfied through the issuance of notes

-

-

-

-

-

-

-

0

0

Depreciation

73

74

36

25

15

15

5

7

12

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

171

-220

220

0

-

Decrease in trade receivables

-10

-51

47

-307

248

85

2

0

-

Decrease in inventory

-59

-165

100

-79

38

558

80

0

-

(Increase) decrease in prepaid expenses and other current assets

67

-23

-869

505

645

-72

195

-503

17

Security deposits

-

-

-

-

-

-

-

0

0

Increase (decrease) in accounts payable

-1,564

782

157

-63

825

8

10

-15

-170

Decrease in accrued expenses

-363

997

2,022

-

-

-

-

-

-

Increase in accrued expenses

-

-

-

1,121

764

522

448

-18

-

Accrued interest, related parties

-

-

-

-

-

-

-16

0

-

Decrease in deferred revenue

-8

-76

-25

-52

113

41

0

-

-

Accrued expenses and accrued interest

-

-

-

-

-

-

-

-

-139

Deferred rent

-

-

-

-

-

-

-4

-2

-2

Net cash used in operating activities

-15,052

-23,700

-28,587

-22,265

-12,526

-6,320

-3,618

-2,276

-6,296

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of short-term investments

-

-

13,074

0

-

-

-

-

-

Purchase of short-term investments

14,106

-

-

-

-

-

-

-

-

Sale of short-term investments

-

-

-

-11,478

23,592

0

-

-

-

Sale of short-term investments

2,122

1,604

23,583

-

-

-

-

-

-

Purchase of equipment

36

48

151

58

15

25

35

0

1

Net cash provided by (used in) investing activities

-12,020

1,555

10,357

11,419

-23,608

-25

-35

0

-1

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock from at-the-market program, net

15,234

21,968

5,543

6,229

28,451

0

-

-

-

Proceeds from sale of Series F non-voting preferred stock, net

-

-

1,877

0

-

-

-

-

-

Proceeds from short swing profit recovery

-

-

-

-

26

0

-

-

-

Repurchase of outstanding warrants

-

-

-

-

-

-

33

0

-

Proceeds from sale of common stock

-

-

299

0

-

-

-

0

0

Proceeds from notes payable to related parties

-

-

-

-

-

-

-

597

0

Proceeds from senior convertible note

-

7,500

-

-

-

-

686

598

0

Payment of debt issuance costs in connection with senior convertible note

-

108

-

-

-

-

-

-

-

Repayment of amounts loaned under related party notes

-

-

-

-

-

-

-

0

0

Proceeds from exchange agreement, related party

2,000

-

12,798

0

0

6,723

1,033

0

0

Proceeds from senior convertible notes, related party, net

-

-

-

-

-

-

686

0

-

Proceeds from Series C-1 preferred stock, net

-

-

-

-

-

-

1,463

0

-

Proceeds from Series C-2 preferred stock, related party, net

-

-

-

-

-

-

1,463

0

-

Proceeds from Series C-3 preferred stock, net

-

-

-

-

0

743

0

-

-

Proceeds from Series C-3 preferred stock, related party

-

-

-

-

0

575

0

-

-

Proceeds from exercise of warrants

8,673

26

0

-

14,658

0

60

0

-

Proceeds from senior convertible note

-

-

0

-

-

-

-

-

-

Proceeds from Galenica, Ltd. promissory note

-

-

-

-

-

-

-

0

0

Payments of financing fees

226

-

0

-

0

2

157

70

0

Proceeds from exercise of stock options

122

11

6

863

492

318

2

0

-

Net cash provided by financing activities

25,804

29,397

20,524

7,092

43,629

8,357

5,204

1,126

0

Foreign exchange effect on cash

-2

-7

19

0

-16

-46

-11

0

-

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-1,270

7,244

2,315

-3,752

7,477

1,965

1,538

-1,149

-6,298

Supplemental Disclosure of Non-Cash Financing Activities:
Issuance of common stock for payment of deferred fees

-

173

10

0

-

-

-

-

-

Right-of-use asset and lease liability recognized under ASC 842

5

-

-

-

-

-

-

-

-

Unrealized gain from investments

-

-

13

11

-24

0

-

-

-

Conversion of notes payable and accrued interest to common stock, fair value

-

-

-

-

-

-

1,768

0

0

Exchange of convertible notes to preferred stock

-

-

-

-

-

-

1,119

0

-

Conversion of preferred stock to common stock

0

-

0

0

0

2,447

602

0

-

Cash paid for interest

12

1

5

1

3

2

118

0

0

Supplemental Disclosure of Non-Cash Financing and Investing Activities:
Deemed dividend as a result of warrant modification

369

-

-

-

-

-

-

-

-

Deemed dividend as a result of exchange of convertible note, Series C-2, Series D and Series F convertible preferred shares, related party

26,733

-

-

-

-

-

-

-

-

Non-cash portion of debt discount on senior convertible notes

-

1,271

-

-

-

-

-

-

-

Settlement of accrued dividends with issuance of preferred stock

-

-

-

-

0

102

0

-

-

Issuance of common stock for vested restricted stock units

0

0

0

-

-

-

-

-

-

Write-off of fully depreciated computer equipment

47

-

-

-

-

-

-

-

-

Conversion of accounts payable and accrued expenses to preferred stock

-

-

-

-

0

645

0

-

-

Reclassification of derivative liabilities to equity

-

-

3,910

0

0

17,955

0

0

0

Conversion of wages and fees to common stock

-

-

-

-

50

96

0

-

-

Dividend, including deemed dividends

-

-

-

-

33

82

384

0

-

Stock issued to technology finders and licensors

-

-

-

-

-

-

-

0

0

Warrants issued to placement agent

-

-

-

-

-

-

-

106

0

Debt discount on senior convertible notes

-

-

-

-

-

-

-

1,333

0

Accrued deferred financing costs

-

-

-

-

-

-

2

30

-

Accrued and unpaid deferred financing cost

-

-

-

-

-

-

-

-

0